Applied Health Economics and Health Policy

Article	Citations
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review	114
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities	62
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil	38
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–2020	36
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	36
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework	32
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context	32
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach	28
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China	26
Population Norms for SF-6Dv2 and EQ-5D-5L in China	23
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis	22
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions	20
Correction to: The Cost Effectiveness of Taxation of Sugary Foods and Beverages: A Systematic Review of Economic Evaluations	19
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines	19
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches	19
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand	18
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment	17
The Effect of Price Changes and Teaspoon Labelling on Intention to Purchase Sugar-Sweetened Beverages: A Discrete Choice Experiment	17
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom	17
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana	16
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective	16
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?	15
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis	14
How is Value Defined in Molecular Testing in Cancer? A Scoping Review	14
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies	14

The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates	14
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?	14
Including Pharmaceuticals in Bundled Payments	13
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China	13
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	13
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach	13
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients	13
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts	12
Social Costs of Smoking in the Czech Republic	11
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars	10
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon	10
Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores	10
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India	10
Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom	10
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes	9
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making	9
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	9
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy	9
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	9
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?	9
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia	9
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers	9
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study	9
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi	9
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment	8
Effect of Competition on Generic Drug Prices	8
Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia	8
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland	8
Trump’s Drug Pricing Order and the Domestic Economic Trade-Off	8
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective	8
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment	8
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models	8
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040	8
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries	8
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature	7
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis	7
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older	7
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis	7
Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India	7
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework	7
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting	7
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians	7
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance	7
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value	7
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges	7
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study	7
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review	6
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold	6
Estimated Carbon Savings from Changing Surgical Trends in Primary Elective Total Hip Arthroplasty in England: A Retrospective Observational Study	6
Headroom Analysis for Early Economic Evaluation: A Systematic Review	6

Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children	6
EQ-5D-5L Population Norms for Italy	6
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review	6
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets	6
Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer	6
From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R	6
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment	6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment	5
Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On	5
Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review	5
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America	5
Acknowledgement to Referees	5
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends	5
Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?	5
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework	5
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries	5
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration	5
How Did the Affordable Care Act Affect Risky Health Behaviors?	5
Correction to: Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting	4
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals	4
Utilising Health Technology Assessment to Develop Managed Access Protocols to Facilitate Drug Reimbursement in Ireland	4
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review	4
The Impact of Alteplase Coverage on Health Equity for the Treatment of Ischemic Stroke in the USA: A Distributional Cost-Effectiveness Analysis	4
Economic Epidemiology: A Framework to Study Interactions of Epidemics and the Economy	4
Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China	4
Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment	4
Correction: Economic Evaluations of Robotic-Assisted Surgery: Methods, Challenges and Opportunities	4
Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward	4
Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)	4
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals	4
Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review	4
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia	4
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China	4
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide	4
Genetic Test Utilization and Cost among Families of Children Evaluated for Genetic Conditions: An Analysis of USA Commercial Claims Data	4
New Horizons? Assessing General Public Preferences for a Wellbeing Economy in the Post-COVID-19 World	4
Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe	4
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany	4
Preferred Attributes of Care Pathways for Obstructive Sleep Apnoea from the Perspective of Diagnosed Patients and High-Risk Individuals: A Discrete Choice Experiment	4
Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations	4
Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand	4
The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review	3
The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review	3
Alternative Payment Models for Innovative Medicines: A Framework for Effective Implementation	3
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis	3
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options	3
Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review	3
Predicting Health Utilities Using Health Administrative Data: Leveraging Survey-linked Health Administrative Data from Ontario, Canada	3
Costs and Cost-Effectiveness of User-Testing of Health Professionals’ Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic	3
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022	3
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology	3
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study	3
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden	3
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry	3
Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations	3
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study	3
Modelling Informal Carers’ Health-Related Quality of Life: Challenges for Economic Evaluation	3
The Short Form 6 Dimensions (SF-6D): Development and Evolution	3
A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis	3
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit	3
Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation	3
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis	2
A Multi-dimensional Framework of Valued Output for Primary Care in England	2
Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions	2
Correction to: Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta‑analysis	2
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities	2
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women	2
Is the Use of Unanchored Matching-Adjusted Indirect Comparison Always Superior to Naïve Indirect Comparison on Survival Outcomes? A Simulation Study	2
Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana	2
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach	2
The Gift of Time, How Do I Want to Spend It? Exploring Preferences for Time Allocation Among Women with and without a Breast Cancer Diagnosis	2
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers	2
Economic Evaluation of an Intervention Designed to Reduce Bullying in Australian Schools	2
A Contingent Valuation Study for Use in Valuing Public Goods with Health Externalities: The Case of Street Pianos	2
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences	2
Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	2
The Impact of the Approach to Accounting for Age and Sex in Economic Models on Predicted Quality-Adjusted Life-Years	2
Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries	2
Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections	2
The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis	2

Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?	2
Are Drug Novelty Characteristics Associated With Greater Health Benefits?	2
Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”	2
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis	2
Cost of Carbon in the Total Cost of a Healthcare Procedure: Example of Micro-Costing Study in a French Setting	2
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update	2
Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults	2
Episcissors-60 for Mediolateral Episiotomy: Evaluation of Clinical and Economic Evidence to Inform NICE Medical Technologies Guidance	2
Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation	2
Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas	2
An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology	2
Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions	2
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic	2
Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?	2
Real-World Health and Economic Effects of a Large-Scale Outpatient Screening and Continuing Care Programme for Early Detection and Care of Microvascular Complications in Patients with Type 2 Diabetes	2
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA	2
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review	2
Acknowledgement to Referees	2